Evidence map›Paper›PMID 40645723›Full record

ArticleJACC. Case reports2025

Digenic Overlap Syndrome Masquerading as Homozygous Familial Hypercholesterolemia.

Samuel D Maidman, Chen Gurevitz, Robert S Rosenson

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Samuel D MaidmanMetabolism and Lipids Program, Icahn School of Medicine at Mount Sinai, Mount Sinai Fuster Heart Hospital, New York, New York, USA.
Chen GurevitzMetabolism and Lipids Program, Icahn School of Medicine at Mount Sinai, Mount Sinai Fuster Heart Hospital, New York, New York, USA.
Robert S RosensonMetabolism and Lipids Program, Icahn School of Medicine at Mount Sinai, Mount Sinai Fuster Heart Hospital, New York, New York, USA. Electronic address: Robert.Rosenson@mssm.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe development of tendinous xanthomas in childhood with a low-density lipoprotein (LDL) cholesterol level >400 mg/dL is characteristic of homozygous familial hypercholesterolemia (FH). CASE SUMMARY: We present the case of a patient with a severely elevated LDL cholesterol level and childhood-onset xanthomas who fulfilled clinical criteria for homozygous FH. However, genetic and absorption testing clarified his phenotype to be a unique digenic overlap of both heterozygous FH and heterozygous sitosterolemia with marked elevations in cholesterol absorption indices. Treatment with ezetimibe 10 mg daily resulted in a dramatic reduction in LDL cholesterol. DISCUSSION: Sitosterolemia, a rare autosomal recessive disorder of plant sterol hyperabsorption, can also result in xanthomatosis and thus can mimic FH. Although it is usually a homozygous disease, heterozygotes may exhibit intermediary phenotypes. TAKE-HOME MESSAGES: Patients with severe hypercholesterolemia should undergo genetic and biochemical profiling for diagnostic confirmation and for ensuring that they receive optimal, personalized therapy.

Indexed as

ABCG8familial hypercholesterolemiaLDLRsitosterolemiaxanthomas

Identifiers

PMID40645723
PMCPMC12441403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.